Sofregen Inc. specializes in developing innovative biomaterials for medical and aesthetic applications, particularly focusing on the use of silk proteins. Their proprietary technology harnesses the unique properties of silk fibroin, which is derived from silkworms, to create a range of products that promote tissue regeneration and healing. This biocompatible and biodegradable material is designed to support the body’s natural healing processes, making it suitable for various applications, including soft tissue repair and aesthetic procedures.

The company’s product pipeline includes advanced solutions for surgical and cosmetic uses, leveraging the natural strength and versatility of silk. Sofregen's technologies aim to enhance patient outcomes by providing scaffolds that facilitate cellular growth and integration, thereby improving the effectiveness of treatments. Their commitment to scientific research and development underpins their approach, ensuring that their products are not only effective but also safe for use in clinical settings.

United States

Sofregen is a manufacturer of a biomedical silk protein intended to facilitate soft-tissue bulking and regeneration for a range of procedures in medical aesthetics and other medical applications. Sofregen's Silk Voice®, a silk protein injectable implant & catheter, was cleared by the U.S. FDA in 2019 for vocal fold medialization and vocal fold insufficiency.

Sofregen Inc.

Company Details